A retrospective study was performed to determine the grade of oral mucositis and compare it to the frequency of opioid use in patients receiving radiotherapy or chemoradiotherapy for head and neck tumors. We classified 249 patients into three groups according to the radiation dose given in the oral cavity (Group A: 0Gy, 73 patients; Group B:<40Gy, 66 patients; Group C≥40Gy; 110 patients). The incidences of Gr.2 oral mucositis were 4.1%, 28.8% and 75.5% of the patients in groups A, B and C, respectively. Opioids were used by 12.3%, 30.3% and 44.5% of the patients in groups A, B and C, respectively, and there was a significant difference in frequency of opioid use among 3 groups (P<0.001). In Group C, there was a significant correlation between the severity of oral mucositis and frequency of opioid use (P<0.001).
In other words, an opioid was used for head and neck tumors treated with a radiation dose in the oral cavity of more than 40Gy, depending on severity of oral mucositis.
View full abstract